Science Explorer Interactive view Map
Company · Boulder · United States

Clovis Oncology (United States)

clovisoncology.comROR OpenAlex
World rank, all time
#33,056
of 42,892
Rank in United States
#7,052
of 8,685
Research works
125
▲ 36% vs 2013–17
Citations
3k
23.8 per fractional work
Top-10% rate
24.0%
record average 16.5%
Open access
41%
world 28%

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 2.68× its world share, 4 worksBiochemistry, Geneti…Immunology and Microbiology: 4.31× its world share, 1 worksImmunology and Micro…Neuroscience: 1.82× its world share, 1 worksNeuroscienceChemical Engineering: 0.54× its world share, 0 worksChemical EngineeringChemistry: 0.75× its world share, 0 worksChemistryComputer Science: 0.17× its world share, 0 worksComputer ScienceEngineering: 0.45× its world share, 2 worksEngineeringEnvironmental Science: 0.35× its world share, 0 worksEnvironmental ScienceMaterials Science: 0.16× its world share, 0 worksMaterials ScienceHealth Professions: 0.88× its world share, 1 worksHealth ProfessionsMedicine: 3.12× its world share, 18 worksMedicineBusiness, Management and Accounting: 0.24× its world share, 0 worksBusiness, Management…Decision Sciences: 0.39× its world share, 0 worksDecision SciencesEconomics, Econometrics and Finance: 0.10× its world share, 0 worksEconomics, Econometr…Social Sciences: 0.24× its world share, 1 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 4.3×. Every wedge is a field page.

Who are the top researchers at Clovis Oncology (United States)?

Ranked on the composite score, Lara Maloney, Sandra Goble and Mitch Raponi lead among researchers whose main affiliation is Clovis Oncology (United States).

  1. 1 Lara Maloney United States · #1,026,332 worldwide 27 citations · 19 works
  2. 2 Sandra Goble United States · #1,123,004 worldwide 37 citations · 28 works
  3. 3 Mitch Raponi United States · #1,127,571 worldwide 59 citations · 23 works
  4. 4 T. Cameron United States · #1,172,687 worldwide 19 citations · 16 works
  5. 5 Andrew D. Simmons United States · #1,435,938 worldwide 23 citations · 19 works
All ranked researchers at Clovis Oncology (United States)

Which keywords describe research at Clovis Oncology (United States)?

By fractional works in 2022–2025, weighted toward what it does more of than the world: Cancer Therapy, Immunotherapy, Homologous Recombination, Cell Death, BRCA Mutation, PARP Inhibitors, Metastasis and Tumor Microenvironment.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 22 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 22 words, with their numbers
  1. Cancer Therapy4▲ 25×6 topics
  2. Immunotherapy3▲ 13×8 topics
  3. Homologous Recombination3▲ 200×2 topics
  4. Cell Death2▲ 36×4 topics
  5. BRCA Mutation2▲ 357×1 topic
  6. PARP Inhibitors2▲ 357×1 topic
  7. Metastasis2▲ 23×8 topics
  8. Tumor Microenvironment2▲ 16×5 topics
  9. PET Imaging2▲ 38×2 topics
  10. Clinical Trials2▲ 9.2×6 topics
  11. Biomarkers2▲ 8.7×5 topics
  12. Epidemiology2▲ 1.43×10 topics
  13. Angiogenesis2▲ 17×2 topics
  14. Targeted Therapy2▲ 22×5 topics
  15. Chemotherapy1▲ 6.5×6 topics
  16. Fibroblast Activation Protein1▲ 91×1 topic
  17. Immunosuppression1▲ 44×1 topic
  18. Ovarian Cancer1▲ 45×2 topics
  19. Genetic Mutations1▲ 8.3×3 topics
  20. Genomic Analysis1▲ 15×2 topics
  21. Depression1▲ 4.1×3 topics
  22. Healthcare1▲ 3.2×6 topics

Which research topics does Clovis Oncology (United States) publish most on?

By volume in 2022–2025: PARP inhibition in cancer therapy, Peptidase Inhibition and Analysis, Ovarian cancer diagnosis and treatment and Cancer Immunotherapy and Biomarkers.

PARP inhibition in cance…2PARP inhibition in cancer therapy: 2 fractional worksPeptidase Inhibition and…1Peptidase Inhibition and Analysis: 1 fractional worksOvarian cancer diagnosis…1Ovarian cancer diagnosis and treatment: 1 fractional worksCancer Immunotherapy and Biomarkers: 1 fractional worksBiomedical and Engineering Education: 1 fractional worksRadiopharmaceutical Chemistry and Applications: 1 fractional worksMonoclonal and Polyclonal Antibodies Research: 1 fractional worksCAR-T cell therapy research: 1 fractional worksElectroconvulsive Therapy Studies: 0 fractional worksNeuropeptides and Animal Physiology: 0 fractional works
OncologyReproductive MedicineBiomedical EngineeringRadiology, Nuclear Medicine and Imaging2 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 PARP inhibition in cancer therapy Oncology 2 works
  2. 2 Peptidase Inhibition and Analysis Oncology 1 works
  3. 3 Ovarian cancer diagnosis and treatment Reproductive Medicine 1 works
  4. 4 Cancer Immunotherapy and Biomarkers Oncology 1 works
  5. 5 Biomedical and Engineering Education Biomedical Engineering 1 works
  6. 6 Radiopharmaceutical Chemistry and Applications Radiology, Nuclear Medicine and Imaging 1 works
  7. 7 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 1 works
  8. 8 CAR-T cell therapy research Oncology 1 works
  9. 9 Electroconvulsive Therapy Studies Psychiatry and Mental health 0 works
  10. 10 Neuropeptides and Animal Physiology Cellular and Molecular Neuroscience 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available40.9%not open59.1%

World: 28% of research is openly available.

with international co-authors36.9%domestic only63.1%

World: 19% is written across borders.

How has Clovis Oncology (United States)'s research output changed?

Output in 2018–2022 was 36% higher than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Boulder

All research institutions in Boulder

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.